700 patients110,866 observations180 daysLIVE

Patient P-02455

Synthetic patientMETA-24 · Day 176 · 25–34 · F · baseline S09Open companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
8%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S09
  2. Day 14 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 22 DT-01 recommendedDosing / Timing Recommendation DT-01
  4. Day 23 Patient acceptedStarted DT-01 in the companion
  5. Day 28 GI symptom burden −15% vs expectedDosing / Timing Recommendation DT-01
  6. Day 34 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • GI instability-12
  • Nutritional resilience+9
  • Inflammatory activity-2
  • Toxicity+2

What helped?

  • Dosing / Timing Recommendation DT-01Day 22
    Result: symptom burden −15%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 60
    • MicrobiomeButyrate capacity 42/100
    • MicrobiomeF. prausnitzii depleted
  • Inflammatory signalling 35
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 38 ms, trending down
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 1.9 · butyrate capacity 42/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
40 ms
Sleep
7.3 h
Steps
4,805
Resting HR
61 bpm
Daily log: GI score 14, nutritional resilience 69, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0249456%S09GI-04improved47
P-0205854%S05GI-04no change48
P-0251353%S16GI-04no change46
P-0235152%S1651
P-0203351%S06GI-04improved51
P-0216951%S1743
P-0233651%S2050
P-0207050%S1155
P-0244850%S1052
P-0233049%S15DT-01no change57
P-0235549%S09GI-04improved55
P-0239149%S19HY-01improved53